{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:56Z","timestamp":1786119596806,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1097\/ico.0b013e3181d92834","type":"journal-article","created":{"date-parts":[[2010,8,27]],"date-time":"2010-08-27T11:16:08Z","timestamp":1282907768000},"page":"1268-1272","source":"Crossref","is-referenced-by-count":17,"title":["Perilimbal Bevacizumab Injection for Interface Neovascularization After Deep Anterior Lamellar Keratoplasty"],"prefix":"10.1097","volume":"29","author":[{"given":"Alireza","family":"Foroutan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beigzadeh","family":"Fariba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bakhtiari","family":"Pejman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshaghani","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghasemi Falavarjani","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehteshami Afshar","family":"Arash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooria","family":"Foroutan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210204","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00003226-198706040-00004","article-title":"Corneal neovascularization pathogenesis and inhibition.","volume":"6","author":"Epstein","year":"1987","journal-title":"Cornea"},{"key":"R2-12-20210204","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/j.jcrs.2007.07.012","article-title":"Perilimbal bevacizumab for vascularized rejected corneal graft.","volume":"33","author":"Awadein","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"R4-12-20210204","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/00003226-199811000-00008","article-title":"Angiogenesis in corneal disease: Histopathologic evaluation of 254 human corneal buttons with neovascularization.","volume":"17","author":"Cursiefen","year":"1998","journal-title":"Cornea"},{"key":"R5-12-20210204","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/bjo.2006.107912","article-title":"Inhibition of experimental corneal neovascularization by bevacizumab (Avastin).","volume":"91","author":"Manzano","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R6-12-20210204","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1442-9071.2007.01572.x","article-title":"Bevacizumab inhibits corneal neovascularization in an alkali burn induced model of corneal angiogenesis.","volume":"35","author":"Hosseini","year":"2007","journal-title":"Clin Experiment Ophthalmol"},{"key":"R7-12-20210204","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00417-007-0587-4","article-title":"Perilimbal bevacizumab for corneal neovascularization.","volume":"245","author":"Erdurmus","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R8-12-20210204","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N Engl J Med"},{"key":"R9-12-20210204","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1442-9071.2006.01378.x","article-title":"Rapid resolution of severe disc new vessels in proliferative diabetic retinopathy following a single intravitreal injection of bevacizumab.","volume":"34","author":"Isaacs","year":"2006","journal-title":"Clin Exp Ophthalmol"},{"key":"R10-12-20210204","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1167\/iovs.06-0433","article-title":"Intravitreal bevacizumab for choroidal neovascularization caused by AMD (IBeNA study): result of a phase 1 dose escalation study.","volume":"47","author":"Costa","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R11-12-20210204","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1034\/j.1600-0420.2001.790308.x","article-title":"Risk factors for corneal graft failure and rejection in penetrating keratoplasty.","volume":"79","author":"Inoue","year":"2001","journal-title":"Acta Ophthalmol Scand"},{"key":"R12-12-20210204","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3928\/1542-8877-20050701-14","article-title":"Optical coherence tomography findings after intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration.","volume":"36","author":"Rosenfeld","year":"2005","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"R13-12-20210204","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1006\/exer.1993.1177","article-title":"The effect of angiostatic steroids and B Cyclodextrin tetradecasulfate on corneal neovascularization in the rats.","volume":"57","author":"Proia","year":"1993","journal-title":"Exp Eye Res"},{"key":"R14-12-20210204","first-page":"1588","article-title":"Effects of inhibitors of arachidonic acid metabolism on corneal neovascularization in the rat.","volume":"30","author":"Haynes","year":"1989","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R15-12-20210204","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/0002-9394(79)90245-9","article-title":"Suppressive effects of indomethacin on thermally induced neovascularization of rabbit corneas.","volume":"87","author":"Deutsch","year":"1979","journal-title":"Am J Ophthalmol"},{"key":"R16-12-20210204","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/exer.1998.0512","article-title":"The heparan sulfate suleparoide inhibits rat corneal angiogenesis and in vitro neovascularization.","volume":"67","author":"Benelli","year":"1998","journal-title":"Exp Eye Res"},{"key":"R17-12-20210204","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/archopht.1992.01080150103037","article-title":"Suppression of corneal neovascularization with cyclosporine.","volume":"110","author":"Lipman","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"R18-12-20210204","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s004170050387","article-title":"Topical application of methotrexate for inhibition of corneal angiogenesis.","volume":"237","author":"Joussen","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R19-12-20210204","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","article-title":"Thalidomide is an inhibitor of angiogenesis.","volume":"91","author":"DAmato","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"R20-12-20210204","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/exer.1998.0527","article-title":"Photodynamic effect of a new photosensitizer ATX-S10 on corneal neovascularization.","volume":"67","author":"Gohto","year":"1998","journal-title":"Exp Eye Res"},{"key":"R21-12-20210204","first-page":"2148","article-title":"Fine needle diathermy occlusion of corneal vessels.","volume":"41","author":"Pillai","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R22-12-20210204","first-page":"2510","article-title":"Inhibition of inflammatory corneal angiogenesis by TNP-470.","volume":"42","author":"Joussen","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R23-12-20210204","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00417-002-0591-7","article-title":"Inhibition of experimental angiogenesis of cornea by somatostatin.","volume":"241","author":"Wu","year":"2003","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R24-12-20210204","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00417-009-1170-y","article-title":"Avastin use in high risk corneal transplantation.","volume":"247","author":"Vassileva","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R25-12-20210204","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/ICO.0b013e318159019f","article-title":"Subconjunctival bevacizumab injection for corneal neovascularization.","volume":"27","author":"Bahar","year":"2008","journal-title":"Cornea"},{"key":"R26-12-20210204","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1442-9071.2007.01616.x","article-title":"Are we getting closer to prevention and treatment of corneal neovascularization?","volume":"35","author":"Chevez-Barrios","year":"2007","journal-title":"Clin Exp Ophthalmol"},{"key":"R27-12-20210204","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1167\/iovs.06-0570","article-title":"Bevacizumab is a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis in the cornea.","volume":"48","author":"Bock","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R28-12-20210204","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ophtha.2005.11.019","article-title":"Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.","volume":"113","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"key":"R29-12-20210204","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00006982-200603000-00004","article-title":"Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage.","volume":"26","author":"Spaide","year":"2006","journal-title":"Retina"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003226-201011000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:40:01Z","timestamp":1786041601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003226-201011000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e3181d92834","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}